Your browser doesn't support javascript.
loading
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.
Stein-Thoeringer, Christoph K; Saini, Neeraj Y; Zamir, Eli; Blumenberg, Viktoria; Schubert, Maria-Luisa; Mor, Uria; Fante, Matthias A; Schmidt, Sabine; Hayase, Eiko; Hayase, Tomo; Rohrbach, Roman; Chang, Chia-Chi; McDaniel, Lauren; Flores, Ivonne; Gaiser, Rogier; Edinger, Matthias; Wolff, Daniel; Heidenreich, Martin; Strati, Paolo; Nair, Ranjit; Chihara, Dai; Fayad, Luis E; Ahmed, Sairah; Iyer, Swaminathan P; Steiner, Raphael E; Jain, Preetesh; Nastoupil, Loretta J; Westin, Jason; Arora, Reetakshi; Wang, Michael L; Turner, Joel; Menges, Meghan; Hidalgo-Vargas, Melanie; Reid, Kayla; Dreger, Peter; Schmitt, Anita; Müller-Tidow, Carsten; Locke, Frederick L; Davila, Marco L; Champlin, Richard E; Flowers, Christopher R; Shpall, Elizabeth J; Poeck, Hendrik; Neelapu, Sattva S; Schmitt, Michael; Subklewe, Marion; Jain, Michael D; Jenq, Robert R; Elinav, Eran.
Afiliación
  • Stein-Thoeringer CK; Division of Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Saini NY; Internal Medicine I, University Clinic Tuebingen, Tuebingen, Germany.
  • Zamir E; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX, USA. nsaini@mdanderson.org.
  • Blumenberg V; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA. nsaini@mdanderson.org.
  • Schubert ML; Division of Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mor U; Medizinische Klinik III, LMU Klinikum, Munich, Germany.
  • Fante MA; Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany.
  • Schmidt S; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.
  • Hayase E; Department of Hematology, Oncology and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.
  • Hayase T; Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Rohrbach R; Department of Internal Medicine III, University Clinic Regensburg, Regensburg, Germany.
  • Chang CC; Division of Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • McDaniel L; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
  • Flores I; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
  • Gaiser R; Division of Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Edinger M; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
  • Wolff D; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
  • Heidenreich M; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
  • Strati P; Division of Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Nair R; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.
  • Chihara D; Department of Internal Medicine III, University Clinic Regensburg, Regensburg, Germany.
  • Fayad LE; Leibnitz Institut für Immuntherapie (LIT), Regensburg, Germany.
  • Ahmed S; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.
  • Iyer SP; Department of Internal Medicine III, University Clinic Regensburg, Regensburg, Germany.
  • Steiner RE; Leibnitz Institut für Immuntherapie (LIT), Regensburg, Germany.
  • Jain P; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.
  • Nastoupil LJ; Leibnitz Institut für Immuntherapie (LIT), Regensburg, Germany.
  • Westin J; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Arora R; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Wang ML; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Turner J; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Menges M; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Hidalgo-Vargas M; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Reid K; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Dreger P; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Schmitt A; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Müller-Tidow C; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Locke FL; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Davila ML; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Champlin RE; Department of Clinical Science, Moffitt Cancer Center, Tampa, FL, USA.
  • Flowers CR; Department of Clinical Science, Moffitt Cancer Center, Tampa, FL, USA.
  • Shpall EJ; Department of Clinical Science, Moffitt Cancer Center, Tampa, FL, USA.
  • Poeck H; Department of Clinical Science, Moffitt Cancer Center, Tampa, FL, USA.
  • Neelapu SS; Department of Hematology, Oncology and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.
  • Schmitt M; Department of Hematology, Oncology and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.
  • Subklewe M; Department of Hematology, Oncology and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.
  • Jain MD; Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center and Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Jenq RR; Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center and Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Elinav E; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX, USA.
Nat Med ; 29(4): 906-916, 2023 04.
Article en En | MEDLINE | ID: mdl-36914893
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B / Microbioma Gastrointestinal / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B / Microbioma Gastrointestinal / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Alemania